Abemaciclib in real clinical practice of adjuvant therapy of HR+/HER2- high-risk breast cancer: experience of centers in Moscow. Вопр. онкол. [Internet]. 2025 Jun. 30 [cited 2026 Oct. 14];71(3):OF-2319. Available from: https://voprosyonkologii.ru/index.php/journal/article/view/3-25-Abemaciclib-in-real-clinical-practice-of-adjuvant